These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26350113)

  • 1. Appropriateness of antithrombotic prophylaxis in the oldest old with non-valvular atrial fibrillation: ARAPACIS and REPOSI.
    Mannucci PM; Nobili A
    Eur J Intern Med; 2015 Nov; 26(9):e47-8. PubMed ID: 26350113
    [No Abstract]   [Full Text] [Related]  

  • 2. Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study.
    Pignatelli P; Pastori D; Perticone F; Corazza GR; Violi F;
    Eur J Intern Med; 2015 Oct; 26(8):e31-3. PubMed ID: 26123820
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients.
    Larsen TB
    Europace; 2015 Feb; 17(2):169-70. PubMed ID: 25341743
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
    Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
    Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AÇ; Kalaycıoğlu E; Bolat I; Taşar O; Şafak Ö; Kalçık M; Yaman M; İnci S; Altıntaş B; Kalkan S; Kırma C; Biteker M;
    J Thromb Thrombolysis; 2017 Feb; 43(2):157-165. PubMed ID: 27848065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
    Renoux C; Coulombe J; Suissa S
    BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma C; Zint K; Elsaesser A; Bartels DB; Lip GY;
    Am J Med; 2015 Dec; 128(12):1306-13.e1. PubMed ID: 26239094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals.
    Cheng TO
    Stroke; 1997 Apr; 28(4):874. PubMed ID: 9099212
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perception of physicians on factors that influence the choice of a dicoumarin or a new oral anticoagulant in patients with non-valvular atrial fibrillation].
    Anguita-Sánchez M; Marco-Vera P; Alonso-Moreno FJ; Arribas-Ynsaurriaga F; Gállego-Culleré J; Honorato-Pérez J; Suárez-Fernández C;
    Aten Primaria; 2016 Oct; 48(8):527-534. PubMed ID: 26971361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.
    Raparelli V; Proietti M; Buttà C; Di Giosia P; Sirico D; Gobbi P; Corrao S; Davì G; Vestri AR; Perticone F; Corazza GR; Violi F; Basili S
    Intern Emerg Med; 2014 Dec; 9(8):861-70. PubMed ID: 24990547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thromboembolism in patients with chronic atrial fibrillation in primary health care].
    Martín Acicoya D; Pedrero Pérez P; Martínez García JA; González Alvaro A; Hernando López T; Herreros Hernanz I
    Med Clin (Barc); 2004 Jan; 122(2):53-6. PubMed ID: 14733855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?
    Bista D; Chalmers L; Peterson GM; Bereznicki LRE
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):573-578. PubMed ID: 27071408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012-2013.
    Bajorek BV; Magin PJ; Hilmer SN; Krass I
    Prev Chronic Dis; 2016 Jul; 13():E90. PubMed ID: 27418212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.